Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.240
+0.190 (4.69%)
Jul 9, 2025, 4:00 PM - Market closed
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $32.42 million as of July 9, 2025. Its market cap has increased by 158.55% in one year.
Market Cap
32.42M
Enterprise Value
7.85M
1-Year Change
158.55%
Ranking
Category
Stock Price
$4.24
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $32.42M, a decrease of -55.49%. That is a compound annual growth rate of -20.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 32.40M | -0.56% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.83B |
| Johnson & Johnson | 373.59B |
| AbbVie | 331.43B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 275.51B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 232.62B |
| AstraZeneca | 216.19B |